Predict your next investment

HEALTHCARE | Medical Facilities & Services / Medical Laboratories & Research

See what CB Insights has to offer


Acquired | Acquired

About MIGS

MIGS is a Lebanon, NH-based integrated contract research organization specializing in humanization and the production of antibody and antibody-like molecules that support preclinical studies with microgram to gram quantities of protein.

MIGS Headquarter Location

16 Cavendish Ct #227

Lebanon, New Hampshire, 03766,

United States

Latest MIGS News

iSTAR gains European approval for implant for glaucoma surgery

Nov 24, 2021

iSTAR Medical, a medtech company developing novel minimally-invasive implants for glaucoma surgery (MIGS), has seen its MIGS device, MINIject approved in Europe for open-angle glaucoma patients.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.